BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 21654321)

  • 1. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
    Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
    Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
    Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
    Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
    Piperno A; Girelli D; Nemeth E; Trombini P; Bozzini C; Poggiali E; Phung Y; Ganz T; Camaschella C
    Blood; 2007 Dec; 110(12):4096-100. PubMed ID: 17724144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
    Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
    Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
    Flanagan JM; Peng H; Beutler E
    Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.
    van Deuren M; Kroot JJ; Swinkels DW
    Haematologica; 2009 Sep; 94(9):1297-300. PubMed ID: 19608676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton EH; Acton RT
    BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis.
    Hunt JR; Zeng H
    Am J Clin Nutr; 2004 Oct; 80(4):924-31. PubMed ID: 15447900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.
    Bozzini C; Campostrini N; Trombini P; Nemeth E; Castagna A; Tenuti I; Corrocher R; Camaschella C; Ganz T; Olivieri O; Piperno A; Girelli D
    Blood Cells Mol Dis; 2008; 40(3):347-52. PubMed ID: 18164223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HFE hemochromatosis: pathogenic and diagnostic approach].
    Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
    Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.